Fintech Profile: AlphaSense

Fintech Profile: AlphaSense

Summary

AlphaSense is an artificial intelligence powered search engine, which aggregates relevant global-level information on any industry, company, topic, or trend from a wide range of content sources, enabling financial professionals to search and navigate across multiple content sets and review results on a single screen.

Scope

The new report provides information and insights into AlphaSense, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and target market
- Information on funding, partnerships, and awards it received
- Biography of top management.

Reasons to buy

- Gain insights into AlphaSenses business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its target market and opportunities.

Overview
Product Market Mix
Growth & Impact
Key People
Appendix

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution;

USD 250 View Report

Oxurion NV (THR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The companys ocriplasmin, a recombinant derivative of the plasmin protein, is

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available